Covishield

Human Trials Of Oxford Vaccine 'Covishield' To Begin In India As DCGI Gives Nod To Serum Institute

India Inches Closer Towards Oxford Vaccine, Panel Recommends DCGI To Permit SII For Human Trials

India Readies 5 Sites For Phase 3 Human Trials Of Oxford Covid-19 Vaccine; SII To Start Manufacturing Next Month